Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Dogs sniff-out lung damage bacteria in cystic fibrosis research
Lizzie, one of the three Medical Detection Dogs that worked on the trial.

Researchers assess dogs' ability to detect bacteria at ultra-low concentrations

Medical detection dogs could be used to identify the bacteria that cause lung damage in cystic fibrosis (CF) before it takes hold, according to new research. 

Findings published in the European Respiratory Journal show that medical detection dogs have a very high level of accuracy when asked to identify bacteria associated with serious lung infections.

One of the leading causes of lung damage in CF is infection with bacterial pathogens, the most prevalent being Pseudomonas aeruginosa (Pa). Pa chronically infects some 60 per cent of the 10,000 patients in the UK by adolescence and adulthood.

The study revealed that medical detection dogs can sniff-out Pa bacteria grown in a nutrient liquid that also contains other CF bacterial pathogens. Researchers conclude that dogs could eventually prove more sensitive and cost-effective for screening lower airway infection in CF, compared with existing technologies.

The study was conducted by Imperial College London and Royal Brompton Hospital, in collaboration with Medical Detection Dogs, supported by the Cystic Fibrosis Trust. 

“This is a really exciting development. Advanced technology to detect infections, for example in breath, has proved difficult so far,” explained Professor Jane Davies, from Imperial College London. “The successful training of the dogs on cultured samples will now be used as the foundation for testing patient samples directly.”

In the study, researchers assessed the ability of four dogs to detect Pa from other CF-causing bacteria. The bacteria were grown in the laboratory, filtered out of the solution and presented to the dogs.

The dogs were trained and tested on customised sample presentation stands. During the training period, the dogs were rewarded for identifying Pa correctly with food and the sound of a click.

After training, the dogs were given Pa-positive samples, other cultured bacterial controls or sterile liquid in a random, computer-generated sequence. The dogs indicated a positive sample by stopping or sitting down and were rewarded if correct. 

The samples were then presented to the dogs in a double-blind testing scenario.

“The findings of this world-first study into the ability of dogs to detect Pseudomonas are yet another indicator of their remarkable contribution to saving human lives,” commented Dr Claire Guest, Chief Executive and co-founder of Medical Detection Dogs.

“Pseudomonas is a condition that affects thousands of people each year in the UK alone. I can assure them that Medical Detection Dogs is working very hard to find effective, affordable and sustainable ways to manage their condition.”

Image (C) Medical Detection Dogs.

Become a member or log in to add this story to your CPD history

Petplan Veterinary Awards 2020 open for nominations

News Story 1
 Nominations are open for the 2020 Petplan Veterinary Awards, a prestigious event that pays recognition to some of the UKs most notable veterinary professionals.

We have been recognising the brilliant work of the UKs veterinary professionals through the Petplan Veterinary Awards for 21 years now and every year the standard of entries just gets higher, said James Barnes, head of sales and partnerships at Petplan.

To nominate a colleague for the awards visit, before nominations close on 16th January 2020. Winners will be announced at the awards ceremony on 2 April 2020 in Birmingham. 

Click here for more...
News Shorts
BEVA survey seeks views about antibiotic use in horses

Equine vets are being invited to participate in a BEVA survey that aims to find out more about antimicrobial resistance in equine veterinary practice.

Designed by researchers at the University of Liverpool and incoming BEVA president Tim Mair, the survey aims to fill gaps in knowledge about how antimicrobials are being used in equine practice and the landscape of resistant infections encountered in equine practice.

Researchers hope the results will lead to a greater understanding of the role of antimicrobial treatment and antimicrobial resistance in horses and protect antibiotics for the future of equine and human health.